Scarica l'app Stockscreener
88.41
0.10%
-0.09
Dopo l'orario di chiusura:
88.45
0.04
+0.05%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
3 US Dividend Growth Stocks With Balance Sheet And Payout Focus - simplywall.st
Whistleblower Alleges Medical Giant Bribed Hawaiʻi Provider - Honolulu Civil Beat
Ovarian Cancer Diagnostics Market Size to Reach USD 8.08 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Citi Believes Abbott (ABT) Shares are Undervalued Relative to Business Segments - Insider Monkey
Abbott Laboratories Raised Prices, Prompting Sales Slump - WSJ
Ultrahuman M2 Live: Glucose Tracking Without a Prescription Using Abbott's Lingo Launches in the U.S. - Basic Tutorials
Why Abbott’s Libre Sense glucose sport biosensor keeps endurance athletes wired in - AD HOC NEWS
Abbott Laboratories director John Stratton buys $173,640 in shares - Investing.com
Director at Abbott (NYSE: ABT) buys 2,000 shares in open market - Stock Titan
Abbott Laboratories StockChart focus as shares test support - AD HOC NEWS
Ultrahuman Launches M2 Live in U.S. With Abbott Lingo™ CGM Integration - Digital Health News
Ultrahuman launches M2 Live with Abbott's Lingo glucose sensor - t2ONLINE
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
ABT Stock Quote Price and Forecast - CNN
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation - Yahoo Finance
Abbott Laboratories Stock Capital Return Hits $28 Bil - Trefis
Julie Johnson from Texas’s 32nd District Sells Shares in Abbott Laboratories and Accenture - Investing.com
Big Claims, Little Kids: Recent SDNY Decision Highlights Risks in Advertising (via Passle) - Frankfurt Kurnit Klein & Selz
Hormuz Reopening Trade: 20 Large-Caps Still Below Pre-War LevelsAbbott Laboratories (NYSE:ABT), PepsiC - Benzinga
Texas Rep. Julie Johnson Sold Up to $30K Worth of Abbott Laboratories Stock - Benzinga
How Investors May Respond To Abbott (ABT) Dividend And CE Mark For Dual Glucose‑Ketone Sensor - Yahoo Finance
Can S&P 500 Healthcare Giant Abbott Boost Growth With Libre Duo? - Kalkine Media
How Investors Are Reacting To Abbott (ABT) Pairing Libre Duo Launch With Its Latest Dividend Approval - simplywall.st
Abbott Laboratories (ABT): One of the Best Bargain Stocks to Buy in June - Insider Monkey
Abbott Laboratories Stock (US0028241000): Quiet trading day keeps healthcare name in focus - AD HOC NEWS
Is Abbott (ABT) the Best Longevity Stock to Buy Now? - Insider Monkey
Abbott Laboratories (ABT) Announces Quarterly Dividend of $0.63 - GuruFocus
Abbott Laboratories declares $0.63 dividend - MSN
Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch
Abbott Laboratories Keeps Quarterly Dividend at $0.63 a Share, Payable Aug. 17 to Holders of Record as of July 15 - marketscreener.com
Abbott Laboratories Declares Quarterly Cash Dividend, Payable on August 17, 2026 - marketscreener.com
Abbott recalls heart device monitoring system due to malfunction risk - Cardiovascular Business
Abbott Laboratories Stock (US0028241000): Valuation metrics in focus for S&P 500 healthcare name - AD HOC NEWS
Abbott Laboratories Stock 12‑Month Price Target Cut to $115.5, Implies 29% Upside - TradingView
BofA Securities Maintains Abbott Laboratories(ABT.US) With Buy Rating, Cuts Target Price to $102 - 富途牛牛
BofA Adjusts Price Target on Abbott Laboratories to $102 From $120 - marketscreener.com
Abbott Laboratories seen as strong buy with 21.8–39.4% upside amid undervaluation and growth prospects. - Pluang
Abbott Laboratories (ABT) Stock Valuation Check After Recent Mixed Performance - simplywall.st
Abbott Laboratories $ABT Shares Bought by Parnassus Investments LLC - MarketBeat
IFM Investors Pty Ltd Has $45.53 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Remains Structurally Undervalued (NYSE:ABT) - Seeking Alpha
Abbott Labs is heavily oversold, says Powers Advisory Group's Matt Powers - MSN
Elfun Trusts Exits Abbott Laboratories, Impacting Portfolio by -1.97% - GuruFocus
Smithbridge Asset Management Inc. DE Raises Holdings in Abbott Laboratories $ABT - MarketBeat
Illinois Municipal Retirement Fund Has $28.27 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Dorsey & Whitney Trust CO LLC - MarketBeat
Better medical device stock right now: Abbott Laboratories vs. Dexcom - MSN
This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In - Yahoo Finance
Abbott Offered Faulty Health Plan Option, Ex-Worker Says - Law360
Abbott Diabetes And Cancer Milestones Contrast With Prolonged Share Price Weakness - Yahoo Finance
Abbott (ABT) Dips More Than Broader Market: What You Should Know - Yahoo Finance
Abbott office in Easton part of multi-state portfolio sale - The Business Journals
Abbott Laboratories Hit With Lawsuit Over Healthcare Costs (1) - Bloomberg Law News
Abbott Defeats Account Manager’s Sexualized Workplace Claim - Bloomberg Law News
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story - Yahoo Finance
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
LPL Financial LLC Has $271.74 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
BSX, MDT Top Abbott Laboratories Stock on Price & Potential - Trefis
Abbott Laboratories $ABT Shares Purchased by Deutsche Bank AG - MarketBeat
Abbott Laboratories: A Better Than 5 Years AgoBut Still Not A Buy - Seeking Alpha
3 Large Cap Defensive Dividend Stocks With Underestimated Payout Power - simplywall.st
2.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):